Literature DB >> 8751243

Regional vascular resection using catheter bypass procedure for pancreatic cancer.

A Nakao1, A Harada, T Nonami, T Kaneko, H Takagi.   

Abstract

BACKGROUND/AIMS: To elucidate the indications for extended operation including main vessel resection in pancreatic cancer surgery, a clinical study was performed. The safety and clinical significance of portal vein resection in pancreatic cancer surgery have not yet been obtained in a large series.
MATERIALS AND METHODS: Over a period of more than 10 years, 134 of 212 (63%) patients with pancreatic carcinoma underwent resection by extensive radical surgery. Portal vein resection was performed in 104 of 134 (78%) resected cases using catheter bypass procedure. The postoperative survival was investigated and a clinicopathological study was conducted.
RESULTS: Operative death within 30 days after operation was observed in 11 of 134 (8%) resected cases. Postoperative survival rate correlated with the grade of portal vein invasion, which was diagnosed by preoperative or intraoperative portography. Survival for more than two years after operation was seen in cases of negative invasion on the margins of the resected specimens group even when portal system vein wall invasion was observed.
CONCLUSION: Portal vein resection is performed safely using bypass procedure of the portal vein and is recommended to obtain a tumor-free surgical margin.

Entities:  

Mesh:

Year:  1995        PMID: 8751243

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  4 in total

Review 1.  Vascular invasion in pancreatic cancer: Imaging modalities, preoperative diagnosis and surgical management.

Authors:  Nicolas C Buchs; Michael Chilcott; Pierre-Alexandre Poletti; Leo H Buhler; Philippe Morel
Journal:  World J Gastroenterol       Date:  2010-02-21       Impact factor: 5.742

2.  Anterior approach to the superior mesenteric artery by using nerve plexus hanging maneuver for borderline resectable pancreatic head carcinoma.

Authors:  Shugo Mizuno; Shuji Isaji; Akihiro Tanemura; Masashi Kishiwada; Yasuhiro Murata; Yoshinori Azumi; Naohisa Kuriyama; Masanobu Usui; Hiroyuki Sakurai; Masami Tabata
Journal:  J Gastrointest Surg       Date:  2014-03-25       Impact factor: 3.452

3.  Clinical impact of additional therapy for residual pancreatic cancer.

Authors:  Suguru Yamada; Fuminori Sonohara; Mitsuru Tashiro; Kenta Murotani; Hideki Takami; Masamichi Hayashi; Mitsuro Kanda; Chie Tanaka; Daisuke Kobayashi; Goro Nakayama; Masahiko Koike; Tsutomu Fujii; Yasuhiro Kodera
Journal:  Surg Today       Date:  2019-10-24       Impact factor: 2.549

4.  Isolated pancreatectomy using mesenteric approach.

Authors:  Akimasa Nakao
Journal:  J Hepatobiliary Pancreat Sci       Date:  2021-12-21       Impact factor: 3.149

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.